ABMT:OTC-Advanced Biomedical Technologies Inc (USD)

COMMON STOCK | Medical Devices | OTC

Last Closing Price

USD 0.07

Change

0.00 (0.00)%

Market Cap

USD 5.20M

Volume

0.02M

Avg Analyst Target

N/A

Avg User Target

USD
Average Analyst Rating

N/A

Fundamental Analysis

Verdict


Advanced Biomedical Technologies Inc (ABMT) Stock Analysis:
Based on the Advanced Biomedical Technologies Inc stock forecasts from 0 analysts, the average analyst target price for Advanced Biomedical Technologies Inc is not available over the next 12 months. Advanced Biomedical Technologies Inc’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Advanced Biomedical Technologies Inc is Bearish, which is based on 1 positive signals and 4 negative signals. At the last closing, Advanced Biomedical Technologies Inc’s stock price was USD 0.07. Advanced Biomedical Technologies Inc’s stock price has changed by +0.00% over the past week, +0.00% over the past month and -61.11% over the last year.

No recent analyst target price found for Advanced Biomedical Technologies Inc
No recent average analyst rating found for Advanced Biomedical Technologies Inc

About

Advanced Biomedical Technologies, Inc., a development stage company, designs, develops, manufactures, and markets biomaterial internal fixation devices. It offers polymer osteosynthesis devices, such as surgical screws, binding wires, rods, and related medical devices for the tre ...Read More

Technical Indicators

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2022-01-23 )

Largest Industry Peers for Medical Devices

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
SEMHF Siemens Healthineers AG

N/A

USD79.78B 39.90 24.15
SMMNY Siemens Healthineers AG

N/A

USD75.06B 37.05 24.15
RYLPF Koninklijke Philips N.V

N/A

USD29.27B 7.13 30.12
SONVY Sonova Holding AG

N/A

USD22.00B 30.50 22.13
SONVF Sonova Holding AG

N/A

USD21.97B 30.32 22.13
SNNUF Smith & Nephew plc

N/A

USD15.66B 28.25 13.97
WILLF Demant A/S

N/A

USD11.59B 33.08 4.34
WILYY Demant A/S

N/A

USD10.83B 32.59 4.34
GNGBF Getinge AB

N/A

USD9.81B 16.60 1.74
GNGBY Getinge AB

N/A

USD9.79B 16.02 1.74

ETFs Containing ABMT

Symbol Name Weight Mer Price(Change) Market Cap

N/A

Market Performance

  Market Performance vs.
Industry/Classification (Medical Devices)
Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Trailing 12 Months  
Capital Gain -61.11% 24% F 17% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -61.11% 24% F 17% F
Trailing 5 Years  
Capital Gain -30.00% 53% F 36% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -30.00% 53% F 35% F
Average Annual (5 Year Horizon)  
Capital Gain 28.77% 52% F 63% D
Dividend Return N/A N/A N/A N/A N/A
Total Return 28.77% 52% F 62% D-
Risk Return Profile  
Volatility (Standard Deviation) 123.86% 36% F 30% F
Risk Adjusted Return 23.23% 37% F 41% F
Market Capitalization 5.20M 33% F 27% F
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 87%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Key Financial Ratios

  Ratio vs. Industry/Classification
(Medical Devices)
Ratio vs. Market
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio N/A N/A N/A N/A N/A
Price/Book Ratio N/A N/A N/A N/A N/A
Price / Cash Flow Ratio 8.04 21% F 22% F
EV/EBITDA N/A N/A N/A N/A N/A
Management Effectiveness  
Return on Equity N/A N/A N/A N/A N/A
Return on Invested Capital 15.07% 70% C- 80% B-
Return on Assets -78.11% 28% F 12% F
Debt to Equity Ratio N/A N/A N/A N/A N/A
Technical Ratios  
Short Ratio N/A N/A N/A N/A N/A
Short Percent N/A N/A N/A N/A N/A
Beta -1.29 92% A- 93% A
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 97%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Ratings

Target Price Action Rating Action Analyst Rating Price Date

No discussions yet

User / Independent Analyst Ratings

User Name Target Rating Target Horizon (Months) Target Price User Analysis Date Comment

Fundamental Analysis Breakdown

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Positive cash flow

The company had positive total cash flow in the most recent four quarters.

What to not like:
Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.

Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.